Breakthrough Medical Devices Enable Millions to Freely Walk Again

Asking PriceNot Disclosed

Cash Flow
Not Disclosed

EBITDA$4,425,360

Gross Revenue$10,181,700

InventoryNot Disclosed

FF&ENot Disclosed

Real EstateNot Disclosed

GlideTrackSave

Breakthrough Medical Devices Enable Millions to Freely Walk Again


Asking PriceNot Disclosed

Cash Flow
Not Disclosed

EBITDA$4,425,360

Gross Revenue$10,181,700

InventoryNot Disclosed

FF&ENot Disclosed

Real EstateNot Disclosed

Business Description
We have an early stage offering that is a breakthrough patented physical therapy devices that has no equal in the global market for unweighting a person so they can regain the strength in their legs and freely walk again. According to Dr. Nancy Byl, Department Physical Therapy and Rehab Science, UC San Francisco School of Medicine stated, “The effects of these devices is so profound, the GlideTrak belongs in every hospital, physical therapy clinic, and home possible.” This device will be disruptive to this niche market, and it has a well-documented and proven record giving back a person’s freedom of movement. We envision explosive growth for a buyer or equity partner that can bring these devices to the public like scooters chairs, Teeter, Peloton, Bowflex or NordicTrack--on TV and the mass media! The videos from the patients tell it best. Once we have the signed NDA we can send the 115 page CIM.
About the Business
Years in Operation
15
Employees
4
Currently Relocatable
Yes
Facilities & Assets
Aldavida has long partnered a manufacturer to build GlideTrak and source GlideCycle, import from Taiwan, warehouse and ship from Chino Ca. All product costs are included FOB in the cost of goods except for onsite insurance cost. A $50 shipping and handling fee is due upon order. This has been a longstanding partnership and is in full force today.
Website
https://aldavidapt.com
Market Outlook / Competition
Patients needing therapy for gait or balance issues are estimated to grow annually by 9% and reach 597M by 2035. Aldavida has the ability to make an impact for a wide range of patients & people who struggle to stay active having just barely scratched the surface of the potential market.

Aldavida does not have much direct competition being the only company in the market to have up to 87% reduction in ground reaction force and 100% body unweighting between steps. The closest competitor has a a significantly higher cost in the $30K-70K price range.
Opportunities for Growth
The Company is positioned for growth, and there are 19 specific ideas in two general areas that the current Owners believe could be developed to take the Company to the next level.
About the Sale
Seller Motivation
Looking for buyer or investor to expand globally on this patented technology
Transition Support
The Owners desire to either continue on as equity partners or contract employees. Included in the sales price is their time for 90 days, and thereafter compensation for their time will be mutually agreed to. They have many ideas to improve the devices and add more products and long-term they would be available for advisory board positions.
Listing Info
ID
2280116
Listing Views
611
Attached DocumentsAttachment Disclaimer

Breakthrough_NDA.pdf


Contact Seller

By clicking the button, you agree to BizQuest's Terms of Use and Privacy Notice.

Business Listed by: Rick Piper Piper Group International, LLC

Listing ID: 2280116 The information on this listing has been provided by either the seller or a business broker representing the seller. BizQuest has no interest or stake in the sale of this business and has not verified any of the information and assumes no responsibility for its accuracy, veracity, or completeness. See our full Terms of Use. Learn how to avoid scams.